Memantine enhances autonomy in moderate
✍
Benoît Rive; Martine Vercelletto; Florence Delamarre Damier; John Cochran; Cléme
📂
Article
📅
2004
🏛
John Wiley and Sons
🌐
English
⚖ 101 KB
## Abstract ## Background Alzheimer's disease (AD) is the leading cause of dementia and its course renders patients functionally disabled. Memantine is the first drug to demonstrate a clinical benefit in the treatment of patients with moderately‐severe to severe AD. ## Objectives Our objective w